Financial results - DORISIMO PHARMA S.R.L.

Financial Summary - Dorisimo Pharma S.r.l.
Unique identification code: 28739241
Registration number: J07/262/2011
Nace: 4773
Sales - Ron
391.139
Net Profit - Ron
23.945
Employees
5
Open Account
Company Dorisimo Pharma S.r.l. with Fiscal Code 28739241 recorded a turnover of 2024 of 391.139, with a net profit of 23.945 and having an average number of employees of 5. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Dorisimo Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 131.098 178.799 200.571 181.290 174.630 199.762 238.328 310.189 329.795 391.139
Total Income - EUR 131.110 183.116 202.100 183.716 178.221 200.699 239.809 315.170 334.914 410.671
Total Expenses - EUR 131.068 174.140 195.852 185.857 191.870 201.995 236.831 297.171 312.110 375.022
Gross Profit/Loss - EUR 43 8.976 6.248 -2.141 -13.649 -1.296 2.977 17.999 22.804 35.649
Net Profit/Loss - EUR 36 7.831 2.509 -3.977 -15.431 -3.254 579 14.910 19.957 23.945
Employees 4 4 4 3 3 3 3 3 4 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 19.3%, from 329.795 euro in the year 2023, to 391.139 euro in 2024. The Net Profit increased by 4.099 euro, from 19.957 euro in 2023, to 23.945 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Dorisimo Pharma S.r.l.

Rating financiar

Financial Rating -
DORISIMO PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Dorisimo Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dorisimo Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Dorisimo Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dorisimo Pharma S.r.l. - CUI 28739241

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 5.513 2.382 1.170 1.137 32.105 22.810 13.810 5.333 1.070 87.549
Current Assets 39.400 67.208 85.297 71.233 80.874 81.620 94.608 118.444 123.296 165.477
Inventories 27.744 45.912 66.262 50.146 53.018 73.421 77.265 86.432 109.213 137.606
Receivables 11.063 4.184 18.153 19.205 25.616 5.920 15.604 29.962 11.518 8.939
Cash 593 17.113 881 1.883 2.239 2.279 1.740 2.049 2.565 18.931
Shareholders Funds 5.587 13.325 15.609 11.345 -4.305 -7.859 -7.105 7.202 27.138 50.931
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 39.327 56.264 70.858 61.025 117.284 112.289 115.524 116.574 97.228 202.095
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 165.477 euro in 2024 which includes Inventories of 137.606 euro, Receivables of 8.939 euro and cash availability of 18.931 euro.
The company's Equity was valued at 50.931 euro, while total Liabilities amounted to 202.095 euro. Equity increased by 23.945 euro, from 27.138 euro in 2023, to 50.931 in 2024.

Risk Reports Prices

Reviews - Dorisimo Pharma S.r.l.

Comments - Dorisimo Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.